Protocolo diagnóstico y terapéutico de los síndromes parkinsonianos

  1. Luquin Piudo, M.R.
  2. Alonso-Navarro, H.
  3. Burguera Hernández, J.A.
  4. Jiménez-Jiménez, F.J.
Aldizkaria:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Argitalpen urtea: 2015

Saila: 11

Zenbakia: 74

Orrialdeak: 4487-4489

Mota: Artikulua

DOI: 10.1016/J.MED.2015.02.017 DIALNET GOOGLE SCHOLAR

Beste argitalpen batzuk: Medicine: Programa de Formación Médica Continuada Acreditado

Laburpena

In this protocol diagnostic-therapeutic diagnostic triage of a patient with rigid-akinetic syndromes in general and Parkinson's disease in particular (most frequent cause syndromes rigid-akinetic) is summarized, both as regards clinical diagnosis as complementary tests and use of biological markers in the differential diagnosis. Treatments used in these syndromes, which has been more effective in Parkinson's disease are also discussed.

Erreferentzia bibliografikoak

  • Alonso-Navarro H, Jiménez-Jiménez FJ, García-Martín E, Agúndez JAG. Ge-nomic and pharmacogenomic biomarkers of Parkinson’s disease. Curr Drug Metab. 2014;15:129-81.
  • Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson di-sease. Arch Neuorl. 1999;56:33-9.
  • Grandas F, Obeso JA, Tolosa E, editors. Tratado sobre la enfermedad de Par-kinson. Madrid: Luzán 5; 2004.
  • Jankovic J, Tolosa E, editors. Parkinson’s disease and movement disorders. 5a ed. Philadelphia: Lippincott Williams & Wilkins; 2007.
  • Jiménez-Jiménez FJ, Luquin MR, Molina JA, Linazasoro G, edito-res. Tratado de los trastornos del movimiento, 2ª ed. Barcelona: Vi-guera Editores S.L.; 2008.
  • Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JAG. Ce-rebrospinal fluid biochemical studies in patients with Parkinson’s disease: towards a potential search for biomarkers for this disease. Front Cell Neurosci. 2014;8:369.